[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]

Year

Day

May 23, 2019
JAMA Oncology Clinical Challenge

Diffuse Hyperpigmentation in a Patient With an Axillary Mass

Abstract Full Text
JAMA Oncol. Published online May 23, 2019. doi:10.1001/jamaoncol.2019.0524

A white man in his 40s with an axillary mass presents with diffuse dark gray skin and eye discoloration after beginning cancer treatment. What is your diagnosis?

May 16, 2019
Original Investigation

Assessment of Whether the American Society of Clinical Oncology’s Value Framework and the European Society for Medical Oncology’s Magnitude of Clinical Benefit Scale Measure Absolute or Relative Clinical Survival Benefit: An Analysis of Randomized Clinical Trials

Abstract Full Text
JAMA Oncol. Published online May 16, 2019. doi:10.1001/jamaoncol.2019.0818

This evidence review and meta-analysis compares the measurement of survival efficacy components of the American Society of Clinical Oncology and European Society for Medical Oncology value frameworks with measures of absolute vs relative survival benefit.

Review

Insights Into Breast Cancer in the East vs the West: A Review

Abstract Full Text
JAMA Oncol. Published online May 16, 2019. doi:10.1001/jamaoncol.2019.0620

This review examines the differences in the epidemiology, tumor and host biology, and treatment of breast cancer in the East compared with the West.

May 15, 2019
Original Investigation

Self-reported Reasons and Patterns of Noninsurance Among Cancer Survivors Before and After Implementation of the Affordable Care Act, 2000-2017

Abstract Full Text
JAMA Oncol. Published online May 15, 2019. doi:10.1001/jamaoncol.2019.1973

This survey study analyzes NHIS data from nearly 18 000 patients with a cancer diagnosis before and after implementation of the Affordable Care Act (ACA) to evaluate patterns and patient-reported reasons for not having health insurance before and after the ACA.

May 9, 2019
Original Investigation

Prognostic Potential of Circulating Tumor DNA Measurement in Postoperative Surveillance of Nonmetastatic Colorectal Cancer

Abstract Full Text
has audio
JAMA Oncol. Published online May 9, 2019. doi:10.1001/jamaoncol.2019.0512

This study examines the prognostic utility and advantages of ctDNA analysis in all 3 stages of nonmetastatic colorectal cancer.

Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer

Abstract Full Text
open access
JAMA Oncol. Published online May 9, 2019. doi:10.1001/jamaoncol.2019.0528

This cohort study investigates the use of longitudinal data from ultradeep sequencing of cell-free DNA in Danish patients with colorectal cancer.

Editorial

Can Circulating Tumor DNA in Early-Stage Colorectal Cancer Be More Than a Prognostic Biomarker?

Abstract Full Text
JAMA Oncol. Published online May 9, 2019. doi:10.1001/jamaoncol.2019.0503
May 2, 2019
Original Investigation

Assessment of Use, Specificity, and Readability of Written Clinical Informed Consent Forms for Patients With Cancer Undergoing Radiotherapy

Abstract Full Text
JAMA Oncol. Published online May 2, 2019. doi:10.1001/jamaoncol.2019.0260

This survey study assesses the readability grade levels of patient informed consent forms used by 89 academic radiation oncology departments across the United States.

×